Assistance Fund: Hypophosphatasia (HPP)

Funded

About

The Assistance Fund: Hypophosphatasia (HPP) program provides invaluable financial support for patients in need of treatments like Miacalcin and Strensiq. This program offers copay grant assistance for copays, coinsurance, and deductibles, as well as financial assistance for other out-of-pocket costs related to FDA-approved treatments for HPP. Key benefits include widespread access through any in-network pharmacy or care site, making treatment more accessible and affordable for eligible recipients.

Insurance requirements: Commercially insured, Medicare / Medicaid

Enrollment Forms

Enrollment Form

Program Requirements

•Valid only for residents in the US and Puerto Rico

•Enrollment Required: Yes

•Coverage Required: No

•Needs Based: Yes

•Activation Required: No

Program Details

•Please note the following:

•1. Copay grant programs provide assistance for copays, coinsurance, and deductibles for FDAapproved treatment for the disease named in the disease program ONLY

•2. Financial assistance grant programs provide assistance for other eligible outofpocket costs, such as health insurance premiums and incidental medical expenses, in addition to copay, coinsurance, and deductible assistance on FDAapproved treatment for the disease named in the disease program

•3. This fund may cover offlabel drugs

•Copay and Financial assistance can be utilized by any innetwork pharmacy or site of care able to dispense the medication or provide treatment

•Program offers conditional approval of 30 days of immediate assistance for open programs where funding is available

•Patients will be asked to provide and verify demographic, insurance, and financial information (additional documentation may be requested)

•Approved patients will be granted assistance through the end of the calendar year unless otherwise specified for the applicable program

Enrollment Forms

Enrollment Form